Mevo Raises $18M for Brazilian Digital Health Expansion

Brazilian digital health innovator Mevo has successfully closed an $18 million funding round, signaling strong investor confidence in its mission to streamline healthcare access. The significant capital infusion was spearheaded by global investment firm Prosus, with active participation from Matrix, Jefferson River Capital, and Floating Point. This latest financial boost follows a substantial Series B investment in 2024, underscoring the company's consistent growth trajectory.

Founded in 2017, Mevo has established itself as a pivotal connector within the Brazilian healthcare ecosystem. Its digital prescription platform serves as a central hub, linking physicians, patients, pharmacies, and pharmaceutical manufacturers. The company has strategically broadened its service offerings beyond prescriptions to encompass appointment scheduling and the facilitation of online medication fulfillment, effectively building a more integrated and patient-centric healthcare journey.

The newly acquired funds are earmarked for strategic expansion initiatives. Mevo plans to enhance its exam scheduling capabilities, develop robust patient support programs, and further scale its burgeoning online pharmacy operations. This expansion aims to solidify its position as a comprehensive digital health solution provider, addressing critical points of friction in patient care pathways.

Mevo's impact is already substantial, with integrations across more than 1,100 healthcare institutions and partnerships with seven major health insurance providers. This extensive network grants the platform access to approximately 30% of Brazil's private healthcare market, a testament to its widespread adoption and utility. Furthermore, its dedicated pharmacy arm, Mevo Shop, collaborates with over 11 pharmacy chains, reaching an impressive network of about 1,600 retail locations nationwide.

The digital health sector in Latin America is experiencing rapid evolution, driven by increasing internet penetration, a growing demand for accessible healthcare, and supportive government initiatives. Companies like Mevo are at the forefront, leveraging technology to bridge gaps in service delivery and improve patient outcomes. The Brazilian healthtech market, in particular, is a dynamic arena, with significant investment flowing into solutions that enhance efficiency and patient experience. This funding round for Mevo aligns with broader trends of digital transformation within healthcare, positioning the company for continued leadership.

The strategic involvement of Prosus, a prominent global consumer internet group with a strong focus on technology investments, highlights the international recognition of Mevo's potential. Their backing, alongside that of other experienced investors, provides not only capital but also valuable strategic guidance as Mevo navigates its next phase of growth. The company's ability to integrate diverse healthcare services onto a single platform presents a compelling model for the future of healthcare delivery in emerging markets.